Onur Yazdan Balçık

6PUBLICATIONS
62CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 26, 2026
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO).

Erman Akkus, Mehmet Kayaalp, Müzeyyen Aslı Ergözoğlu

|Jan 24, 2026
Evaluation of inflammatory parameters and ferritin as prognostic factors in non-small cell lung cancer patients receiving nivolumab immunotherapy.

İsmail Beypınar, Onur Yazdan Balçık, Semiha Urvay

|Nov 24, 2025
Prognostic Effect of KELIM Score of Prostate-Specific Antigen in Hormone-Sensitive Prostate Cancer Patients Treated With Novel Androgen Receptor Inhibitors: Pioneering New Ways.

Yusuf Ilhan, Murat Araz, Ali Fuat Gurbuz

|Oct 15, 2025
Rethinking Neoadjuvant Therapy: A Critical Evaluation of Exclusion Criteria in Gastric Cancer Surgery Studies.

Yusuf Ilhan, Halil Goksel Guzel, Onur Yazdan Balcik

|Sep 03, 2025
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study.

Ogur Karhan, Serdar İleri, Zuhat Urakçı

|Feb 19, 2025
Prognostic value of IMDC score in non-small cell lung cancer receiving immunotherapy: old dog, new tricks? : IMDC in lung cancer immunotherapy.

İsmail Beypınar, Semiha Urvay, Müslih Ürün

Pageof 1

Frequent Collaborators

4 joint publications

Yusuf Ilhan

4 joint publications

Murat Araz

4 joint publications

Hacer Demir

3 joint publications

Semiha Urvay